Galderma Group AG Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	5,207	4,410	4,082	3,760	3,417
Other Revenue	34	30	35	63.6	28.1
Revenue	5,241	4,440	4,117	3,824	3,445
Revenue Growth (YoY)	18.04%	7.85%	7.66%	11.00%	-
Cost of Revenue	1,632	1,355	1,232	1,194	1,034
Gross Profit	3,609	3,085	2,885	2,630	2,411
Selling, General & Admin	2,488	2,151	1,990	1,908	1,711
Research & Development	245	260	287	315.9	342.6
Other Operating Expenses	48	3	2	5.1	7.7
Operating Expenses	2,781	2,414	2,279	2,229	2,062
Operating Income	828	671	606	400.9	349.5
Interest Expense	-203	-352	-561	-398.4	-352.7
Interest & Investment Income	-	12	6	-	-
Currency Exchange Gain (Loss)	-	-11	-29	4.8	72.5
Other Non Operating Income (Expenses)	14	16	31	12.9	-72.8
EBT Excluding Unusual Items	639	336	53	20.2	-3.5
Merger & Restructuring Charges	-	-15	-17	-33.2	-38
Asset Writedown	-	-	-1	-15.2	-19
Legal Settlements	-	-11	-24	-23.7	-19.1
Pretax Income	639	310	11	-51.9	-79.6
Income Tax Expense	26	79	68	45	4.6
Earnings From Continuing Operations	613	231	-57	-96.9	-84.2
Earnings From Discontinued Operations	-	-	-	-1.6	-72
Net Income to Company	613	231	-57	-98.5	-156.2
Minority Interest in Earnings	-	-	-	-	1.9
Net Income	613	231	-57	-98.5	-154.3
Net Income to Common	613	231	-57	-98.5	-154.3
Net Income Growth	165.37%	-	-	-	-
Shares Outstanding (Basic)	236	238	238	5,188	5,188
Shares Outstanding (Diluted)	238	238	238	5,188	5,188
Shares Change (YoY)	-0.08%	0.10%	-95.42%	-	-
EPS (Basic)	2.60	0.97	-0.24	-0.02	-0.03
EPS (Diluted)	2.58	0.97	-0.24	-0.02	-0.03
EPS Growth	165.98%	-	-	-	-
Free Cash Flow	1,072	360	44	9.7	145.8
Free Cash Flow Per Share	4.51	1.51	0.18	0.00	0.03
Dividend Per Share	-	0.166	-	-	-
Gross Margin	68.86%	69.48%	70.08%	68.77%	69.99%
Operating Margin	15.80%	15.11%	14.72%	10.48%	10.14%
Profit Margin	11.70%	5.20%	-1.39%	-2.58%	-4.48%
Free Cash Flow Margin	20.45%	8.11%	1.07%	0.25%	4.23%
EBITDA	1,151	891	818	630	567.3
EBITDA Margin	21.96%	20.07%	19.87%	16.48%	16.47%
D&A For EBITDA	323	220	212	229.1	217.8
EBIT	828	671	606	400.9	349.5
EBIT Margin	15.80%	15.11%	14.72%	10.48%	10.14%
Effective Tax Rate	4.07%	25.48%	618.18%	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.